Celebrating India’s independence, enterprise and progress
news

Manipal Hospital Kanakapura Road Commits to Managing Cancer with Compassion and Competence with Comprehensive Cancer Centre (MCCC) Launch

Feb 6, 2026 · Source: cision
Manipal Hospital Kanakapura Road Commits to Managing Cancer with Compassion and Competence with Comprehensive Cancer Centre (MCCC) Launch

BANGALORE, India, Feb. 6, 2026 -- Strengthening India's fight against cancer, the Manipal Hospitals Group, a trusted name in healthcare, has launched the Manipal Comprehensive Cancer Care Centre (MCCC) at its Kanakapura Road facility. Designed to deliver end-to-end oncology services under one roof, the centre brings together advanced diagnostics, evidence-based treatments and compassionate support for cancer patients.

Southern Reach

A significant healthcare milestone for South Bengaluru, the new centre offers a wide range of comprehensive screening services that enable accurate detection of different cancers and support informed medical decision-making. With a strong focus on cancer awareness, early diagnosis and integrated care, the centre aligns with globally accepted oncology practices that improve outcomes when treatment begins early.

Integrated Approach

Cancer is a complex disease and no two patients present the same way. Modern oncology therefore follows a multimodal, multidisciplinary approach. Keeping this in mind, the centre has been structured to be value-driven, patient-centric and accessible, bringing all major diagnostic and therapeutic services together. From cost-effective medicines and coordinated multi-speciality care to advanced treatment platforms and experienced oncologists, the centre is equipped to manage cancers across all stages with clinical rigour and empathy.

Advanced Technology

The facility introduces internationally validated, state-of-the-art technology used in leading cancer centres worldwide. Services such as psycho-oncology, pain management and palliative care are fully integrated, recognising that cancer care must address both physical symptoms and emotional wellbeing. This ensures continuous support for patients and families throughout diagnosis, treatment and recovery.

Six Sub-specialties

Though organised into six core departments, the centre functions as a single collaborative unit.

Radiation Oncology features a TrueBeam Linear Accelerator, an advanced platform that enables highly precise radiation delivery while minimising exposure to healthy tissues, in line with current clinical standards.

Surgical Oncology offers comprehensive basic and advanced cancer surgeries, including procedures supported by fourth-generation robotic technology. Robotic-assisted surgery is clinically associated with smaller incisions, reduced blood loss and faster recovery in suitable cases. A well-equipped Plastic Surgery unit supports breast, head and neck, and soft tissue cancer reconstructions.

Nuclear Medicine provides both diagnostic and therapeutic services. These include thyroid scans, parathyroid scintigraphy, I-131 scans and specialised imaging for neuroendocrine tumours. Therapeutic services are offered for thyroid cancer, prostate cancer, hepatocellular carcinoma through trans-arterial radio-embolisation, and bone pain palliation, all of which are established nuclear medicine interventions.

Medical Oncology delivers comprehensive outpatient and inpatient care. The department includes a Day Care Chemotherapy unit offering oral and intravenous chemotherapy, immunotherapy, chemotherapy for leukaemia, and autologous bone marrow transplantation for selected patients, following standard oncological indications.

Paediatric Haematology Oncology cares for children from birth to 18 years with solid tumours, blood cancers and benign hematologic disorders. The unit performs autologous and matched allogeneic bone marrow transplants, adhering to recognised paediatric oncology protocols.

Palliative Medicine focuses on pain relief and the management of psychological and social concerns. By supporting shared decision-making, goal-oriented care discussions and advance care planning, the department works to improve quality of life. Early assessment and ongoing symptom management have been shown to make cancer treatment more tolerable and dignified, especially in advanced stages.

Quality Healthcare

Inaugurating the centre on World Cancer Day, Shri Dinesh Gundu Rao, Minister of Health and Family Welfare, Govt. of Karnataka, said, "Manipal Hospitals has earned a strong reputation for quality healthcare at the state and national level. With the launch of a comprehensive cancer care centre on Kanakapura Road, advanced medical services will now be easily accessible to residents of South Bengaluru." He added, "Cancer cases are increasing, but cancer is a treatable disease. There is no need for fear. Early detection and timely treatment significantly reduce life-threatening risks. Through health camps, awareness drives and a door-to-door health campaign, nearly 72 lakh people have been screened, with around 6,500 showing early signs of cancer. For patient convenience, day-care chemotherapy centres have been established in all district hospitals across the state."

Day Care

The centre's Day Care Chemotherapy unit allows patients to receive planned cancer treatment without hospital admission. Patients can return home the same day, maintaining continuity of daily life while receiving high-quality oncology care in a safe, closely monitored environment.

Support Services

Beyond hospital-based treatment, the centre offers Community Oncology and Cancer Rehabilitation services. Community programmes focus on cancer awareness, lifestyle education and low-cost screening, all of which are recognised public health strategies for reducing cancer burden. Post-discharge, patients receive continued care, including supported home care. Cancer rehabilitation services assess individual needs and deliver structured rehabilitation plans to improve physical function, emotional health, daily activity levels and overall quality of life.

With its comprehensive, medically sound and patient-focused model, the Manipal Comprehensive Cancer Care Centre at Manipal Hospital Kanakapura Road stands as a significant step forward in accessible, modern cancer care for Bengaluru and beyond.

For more information, visit: https://www.manipalhospitals.com/kanakapuraroad/doctors-list/cancer-care/

Photo: https://mma.prnewswire.com/media/2888554/MCCC_Kanakapura_Road.jpg

 

Cision View original content to download multimedia:https://www.prnewswire.com/in/news-releases/manipal-hospital-kanakapura-road-commits-to-managing-cancer-with-compassion-and-competence-with-comprehensive-cancer-centre-mccc-launch-302681095.html

Comments (0)

Login to join the conversation

Login / Register

No comments yet. Be the first to comment!

More to Read

Nexteer Reports Record First-Half 2026 Results
news
Aug 12, 2026 1 min

Nexteer Reports Record First-Half 2026 Results

Customer Wins, Technology Milestones and Digital Transformation Advance Motion Control Leadership AUBURN HILLS, Mich. , Aug. 12, 2026 -- Nexteer Automotive (HK 1316) today announced its 2026 interim results, reporting record first-half performance driven by above-market growth, strategic customer wins and continued advancement of next-generation motion control technologies. Revenue for the period was US 2.3 billion, up 4% compared with the first half of 2025, while total customer bookings reached US 3.3 billion. New and conquest business represented 43% of total bookings, and China domestic OEMs (COEMs) accounted for approximately US 1.0 billion, or 30%, reinforcing Nexteer s position as a trusted motion control partner to OEMs across major global markets. As Nexteer marks its 120th anniversary, the company continues to build on its legacy of innovation while accelerating digital transformation to help OEMs improve speed, efficiency, quality and cost competitiveness in an increasingly complex mobility landscape.

Mach Travel Solutions Ltd Q1 FY27 Revenue Jumps 538% YoY to ₹144.33 Crore
news
Aug 12, 2026 1 min

Mach Travel Solutions Ltd Q1 FY27 Revenue Jumps 538% YoY to ₹144.33 Crore

PAT rises 307% YoY as diversified growth strategy gains momentum NEW DELHI , Aug. 12, 2026 -- Mach Travel Solutions Limited (BSE: MACHLTD), formerly known as Mach Conferences & Events Limited, announced its unaudited Q1 FY27 results. Revenue from Operations stood at 144.33 crore, up 538% YoY, while PAT stood at 6.17 crore, up 307% YoY. The Company also recorded Gross Merchandise Value (GMV) of approximately 252 crore, reflecting the scale of travel transactions handled across its diversified platform.

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results
news
Aug 12, 2026 1 min

Cypherpunk Technologies Reports Second Quarter 2026 Financial Results

CAMBRIDGE, Mass. , Aug. 12, 2026 -- Cypherpunk Technologies Inc., (Nasdaq: CYPH) ( Cypherpunk ), today reported financial results for the second quarter ended June 30, 2026. In the second quarter, Cypherpunk built upon the momentum established earlier this year through the disciplined execution of our Zcash digital asset treasury strategy, increasing our treasury holdings to 323,394.38 ZEC, and welcoming Dev Ojha, founder of Valar Group, as an Advisor, said Douglas E. Onsi, President and CEO of Cypherpunk Technologies. Our Leap Therapeutics subsidiary reached alignment with the FDA on a proposed Phase 3 trial in a DKK1-high, second-line, metastatic colorectal cancer population, with objective response rate as the primary endpoint to support accelerated approval and overall survival to support full approval in the United States and registration globally. We are conducting a strategic process to determine the best path to advance sirexatamab, whether as an independently financed spin-out company or with a partner who shares our commitment to cancer patients.

Context Labs Enters Multi-Year Agreement with Trafigura and Acquires Kinertic to Power Carbon-Informed Commodities Trading
news
Aug 12, 2026 1 min

Context Labs Enters Multi-Year Agreement with Trafigura and Acquires Kinertic to Power Carbon-Informed Commodities Trading

Industrial AI platform will connect primary emissions data to operating entities and trading desks in oil, gas and metals across Trafigura s global portfolio AMSTERDAM , Aug. 12, 2026 -- Context Labs B.V. ( Context Labs ), the industrial AI infrastructure company, today announced three connected transactions with Trafigura PTE Ltd ( Trafigura ): the acquisition of Agora (Europe) Limited and its Kinertic carbon-intelligence platform, developed by Trafigura; a strategic equity investment by Trafigura in Context Labs; and a multi-year master services and platform license agreement under which Trafigura will deploy the combined platform across its commodity trading desks, including oil, gas, and metals.

HTX Releases July Performance Report: TradFi Zone Evolves, Reaching Record Daily Trading Volume
news
Aug 12, 2026 1 min

HTX Releases July Performance Report: TradFi Zone Evolves, Reaching Record Daily Trading Volume

APIA, Samoa , Aug. 12, 2026 -- As market narratives shift rapidly, investors increasingly demand broader asset allocation and higher capital efficiency. The ability to capture market opportunities instantly, alongside solid product offerings, earnings, and services, serves as the most direct benchmark for evaluating a trading platform. In July 2026, staying true to its User First principle, HTX delivered a multi-dimensional performance report marked by a 15% month-to-month growth in new registered users, driven by continuous optimization across listings, trading tools, earning products, campaign operations, and ecosystem building.

nubia Neo 5 Max with 7.5-Inch Display Lands as a New PadPhone Category
news
Aug 12, 2026 1 min

nubia Neo 5 Max with 7.5-Inch Display Lands as a New PadPhone Category

SHENZHEN, China , Aug. 12, 2026 -- nubia, a highly personalized and lifestyle smartphone brand committed to bringing pro-level gaming to everyone, announced the global rollout of nubia Neo 5 Max, introducing a new PadPhone category that combines the expansive viewing experience of a compact tablet with the portable control of a gaming console. Built around a segment-leading 7.5-inch display, nubia Neo 5 Max brings together pad-level immersion, console-level control, immersive audio-visual feedback and AI-powered gaming assistance in one versatile device for gaming, entertainment and everyday productivity.

Compunnel Doubles Down on its Digital Business to Lead the Enterprise AI Shift
news
Aug 12, 2026 1 min

Compunnel Doubles Down on its Digital Business to Lead the Enterprise AI Shift

The AI-native digital engineering business unifies four engineering disciplines under its AI-OS framework to help enterprises move from AI pilots to measurable, at-scale business value. NOIDA, India, Aug. 12, 2026 -- Compunnel today announced the restructuring of Compunnel Digital , its digital engineering business, repositioned as an AI-native engineering partner for global enterprises. The repositioning consolidates four engineering disciplines Applied AI Engineering, Data Platforms & Intelligence, Cloud & Platform Engineering, and Autonomous Quality Engineering under AI-OS , the company s integrated enterprise delivery framework, to help clients move from fragmented AI pilots to industrialized, measurable business value.

BASF Agricultural Solutions invests in new Climate Center at its headquarters to strengthen research capabilities
news
Aug 12, 2026 1 min

BASF Agricultural Solutions invests in new Climate Center at its headquarters to strengthen research capabilities

State-of-the-art research facility at Limburgerhof site responds to increasing regulatory and research demands Purpose-built facility will enable controlled, reproducible ecotoxicology studies to support the registration of crop protection products worldwide Investment supports company s innovation strategy LIMBURGERHOF, Germany , Aug. 12, 2026 -- BASF Agricultural Solutions is investing a low double-digit million-euro amount in a new Climate Center at its headquarters in Limburgerhof, Germany. The purpose-built facility will strengthen the company s research and regulatory capabilities and support the generation of scientific data required for the registration of crop protection products worldwide.